Skip to main content

1 in 9 U.S. Children Have Been Diagnosed With ADHD

Medically reviewed by Carmen Pope, BPharm. Last updated on May 23, 2024.

By Dennis Thompson HealthDay Reporter

THURSDAY, May 23, 2024 -- About 1 in 9 American children have ever received an ADHD diagnosis, slightly more than the number of kids currently being treated for the disorder, a new study shows.

About 7.1 million kids (11.4%) have ever been diagnosed with ADHD, according to findings published May 23 in the Journal of Clinical Child & Adolescent Psychology.

Incidence appears to be rising: Approximately 1 million more children ages 3 to 17 had received an ADHD diagnosis in 2022 than in 2016, researchers found.

About 6.5 million children (10.5%) currently live with ADHD, or about 93% of those who’ve ever been diagnosed, researchers found.

Among kids currently dealing with ADHD, about 58% have moderate or severe ADHD and 78% have at least one other disorder, results show.

Nearly 54% of current ADHD patients have been prescribed medication for the disorder, and 44% have received behavioral treatment in the past year, researchers found.

However, nearly one in three kids (30%) haven’t received any ADHD-specific treatment, results show.

ADHD is more common in the United States than in other countries, the researchers found.

For the study, researchers analyzed more than 45,000 interviews conducted as part of the 2022 National Survey of Children’s Health.

“Public awareness of ADHD has changed over time,” the researchers said.

“With increased awareness of symptoms related to attention regulation, ADHD has been increasingly recognized in girls, adolescents and adults,” they added in a journal news release. “Moreover, ADHD has previously been diagnosed at lower rates among children in some racial and ethnic minority groups. With increased awareness, such gaps in diagnoses have been narrowing or closing.”

For example, researchers found that Asian and Hispanic kids have a lower prevalence of diagnosed ADHD than white children.

Also, children living in homes with lower education and income had a higher rate of ADHD than those in wealthier and better-educated families, results show.

And kids covered by public insurance programs like Medicaid or CHIP have higher rates of ADHD than kids covered by private insurance.

Certain parts of the country -- the Northeast, Midwest and South -- had higher rates of childhood ADHD than the West, researchers found. Additionally, ADHD is more common in rural or suburban areas than in urban areas.

These sort of disparities also extend to treatment of ADHD, researchers added.

More kids on public insurance are taking medication than those covered by private plans, and more children in the Midwest and South are taking meds than those in the West.

“Shifts in patterns of treatments may also be affected by changes in the demographic distribution of who receives ADHD diagnoses,” the researchers wrote. “There is evidence that the sex difference for diagnosis of ADHD may be narrowing; in prior years, the ratio of boys to girls diagnosed with ADHD was more than 2:1.”

Sources

  • Taylor & Francis Group, news release, May 23, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

ADHD Patients Could Face Disrupted Access to Meds Following Fraud Case

FRIDAY, June 14, 2024 -- The two top officers of a telehealth company that began to distribute ADHD drugs widely during the pandemic have been charged with health care fraud, the...

FDA Tells Vaccine Makers to Target New COVID Variant for Fall

FRIDAY, June 14, 2024 -- COVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot of the JN.1 variant that spread widely last winter, the...

Just 1 in 20 Animal Studies Yield Treatments That Make it to Humans

FRIDAY, June 14, 2024 -- Animal studies are often considered a first step in finding new drugs and treatments for human diseases, but a new review has discovered that precious few...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.